Generic name: ALISKIREN HEMIFUMARATE 150mg, AMLODIPINE BESYLATE 5mg, HYDROCHLOROTHIAZIDE 12.5mg
Dosage form: tablet, film coated
Medically reviewed by Drugs.com. Last updated on Dec 14, 2020.
2.1 General Considerations
Dose once-daily. The dosage may be increased after 2 weeks of therapy. The maximum recommended dose of Amturnide is 300/10/25 mg.
2.2 Add-on/Switch Therapy
Use Amturnide for patients not adequately controlled with any 2 of the following: aliskiren, dihydropyridine calcium channel blockers, and thiazide diuretics.
Switch a patient who experiences dose-limiting adverse reactions attributed to an individual component—while on any dual combination of the components of Amturnide—to Amturnide at a lower dose of that component to achieve similar blood pressure reductions.
2.3 Replacement Therapy
For patients receiving aliskiren, amlodipine, and HCTZ from separate tablets, substitute Amturnide containing the same component doses.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Amturnide (aliskiren / amlodipine / hydrochlorothiazide)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Drug class: miscellaneous antihypertensive combinations
- FDA Alerts (1)
- FDA Approval History